biohack.The longevity wire
LIVE WIREUpdated · scanning every 6 hours
16:11 Certain gut bacteria linked to slower or faster aging in 123 adults✦16:10 One-time gene edit let 2 of 3 patients stop daily starch, maker says✦10:20 EU approves Enhertu after surgery for a high-risk breast cancer type✦10:17 A pill given around surgery delayed prostate cancer spread in a big trial✦10:13 Mayo studies in mice point to new ways to tame aging 'zombie' cells✦04:22 Targeted drug cut death risk 32% in advanced womb cancer, report says✦04:18 A Stanford 'company' of 37,000 AI programs studied 50,000 drug trials✦04:18 FDA approves pill pair for earlier prostate cancer with DNA-repair flaws✦16:11 Certain gut bacteria linked to slower or faster aging in 123 adults✦16:10 One-time gene edit let 2 of 3 patients stop daily starch, maker says✦10:20 EU approves Enhertu after surgery for a high-risk breast cancer type✦10:17 A pill given around surgery delayed prostate cancer spread in a big trial✦10:13 Mayo studies in mice point to new ways to tame aging 'zombie' cells✦04:22 Targeted drug cut death risk 32% in advanced womb cancer, report says✦04:18 A Stanford 'company' of 37,000 AI programs studied 50,000 drug trials✦04:18 FDA approves pill pair for earlier prostate cancer with DNA-repair flaws
← All story threadsSTORY THREAD

Pfizer's two-pill combo for prostate cancer.

1 report so far. New developments are added to this thread as they happen.

  1. Oct 26, 2026
    FDA APPROVES USE AT AN EARLIER STAGEFDA approval · 599 men

    FDA approves pill pair for earlier prostate cancer with DNA-repair flaws

    US regulators cleared Pfizer's Talzenna with Xtandi for men whose spread prostate cancer still responds to hormone therapy and carries DNA-repair gene flaws.